91 related articles for article (PubMed ID: 11112847)
1. Cytotoxic activity, accumulation, and intracellular distribution of anthracycline antibiotics and their conjugates with the epidermal growth factor in sensitive and resistant MCF-7 cells.
Lutsenko SV; Feldman NB; Gumanov SG; Rodina AV; Severin SE
Biochemistry (Mosc); 2000 Nov; 65(11):1299-304. PubMed ID: 11112847
[TBL] [Abstract][Full Text] [Related]
2. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
Taatjes DJ; Fenick DJ; Koch TH
Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms.
Serafino A; Sinibaldi-Vallebona P; Gaudiano G; Koch TH; Rasi G; Garaci E; Ravagnan G
Anticancer Res; 1998; 18(2A):1159-66. PubMed ID: 9615782
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and antitumor activities of doxorubicin conjugates with the epidermal growth factor and its receptor-binding fragment.
Lutsenko SV; Feldman NB; Severin SE
J Drug Target; 2002 Nov; 10(7):567-71. PubMed ID: 12683724
[TBL] [Abstract][Full Text] [Related]
5. Enhanced glutathione peroxidase expression protects cells from hydroperoxides but not from radiation or doxorubicin.
Liebmann J; Fisher J; Lipschultz C; Kuno R; Kaufman DC
Cancer Res; 1995 Oct; 55(19):4465-70. PubMed ID: 7671261
[TBL] [Abstract][Full Text] [Related]
6. Bombesin and epidermal growth factor potentiate the effect of cytotoxic LH-RH analog AN-152 in vitro.
Krebs LJ; Wang X; Nagy A; Schally AV; Prasad PN; Liebow C
Int J Oncol; 2002 Dec; 21(6):1325-9. PubMed ID: 12429984
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro anti-cancer activities and enhanced cellular uptakes of EGF fragment decorated doxorubicin nano-aggregates.
Park S; Yoo HS
Int J Pharm; 2010 Jan; 383(1-2):178-85. PubMed ID: 19732814
[TBL] [Abstract][Full Text] [Related]
8. Isolation of human KB cell lines resistant to epidermal growth factor-Pseudomonas exotoxin conjugates.
Lyall RM; Hwang JL; Cardarelli C; FitzGerald D; Akiyama S; Gottesman MM; Pastan I
Cancer Res; 1987 Jun; 47(11):2961-6. PubMed ID: 3494506
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of alpha-fetoprotein conjugate with doxorubicin in vitro and in vivo.
Feldman NB; Kiselev SM; Gukasova NV; Posypanova GA; Lutsenko SV; Severin SE
Biochemistry (Mosc); 2000 Aug; 65(8):967-71. PubMed ID: 11002192
[TBL] [Abstract][Full Text] [Related]
10. Extensive intracellular accumulation of ID-6105, a novel anthracycline, in SK-OV-3 ovarian cancer cells.
Shin DH; Choi KS; Park SA; Cho BS; Lee HS; Ryu JS; Kim TY; Lee CK; Song S; Chung YB
Arch Pharm Res; 2008 Oct; 31(10):1355-61. PubMed ID: 18958428
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor promotes epidermal growth factor receptor nuclear accumulation by a pathway dependent on cytoskeleton integrity in human breast cancer cells.
Cortes-Reynosa P; Robledo T; Salazar EP
Arch Med Res; 2009 Jul; 40(5):331-8. PubMed ID: 19766894
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies on anthracycline haloderivatives.
Facchinetti T; Geroni C; Fumagalli A; Giuliani FC
Drugs Exp Clin Res; 1986; 12(8):657-61. PubMed ID: 3463498
[TBL] [Abstract][Full Text] [Related]
13. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.
Hindenburg AA; Baker MA; Gleyzer E; Stewart VJ; Case N; Taub RN
Cancer Res; 1987 Mar; 47(5):1421-5. PubMed ID: 3469017
[TBL] [Abstract][Full Text] [Related]
14. Expression and regulation of luteinizing hormone/human chorionic gonadotropin receptors in ovarian cancer and its correlation to human chorionic gonadotropin-doxorubicin sensitivity.
Gebauer G; Mueller N; Fehm T; Berkholz A; Beck EP; Jaeger W; Licht P
Am J Obstet Gynecol; 2004 Jun; 190(6):1621-8; discussion 1628. PubMed ID: 15284756
[TBL] [Abstract][Full Text] [Related]
15. Decreased production of vascular endothelial growth factor in adriamycin-resistant breast cancer cells.
Kim JA; Cho KB; Kim MR; Park BC; Kim SK; Lee MY; Kang KW
Cancer Lett; 2008 Sep; 268(2):225-32. PubMed ID: 18471962
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition, nuclear uptake, and retention of anthracycline-formaldehyde conjugates in prostate cancer cells relative to clinical anthracyclines.
Taatjes DJ; Koch TH
Anticancer Res; 1999; 19(2A):1201-8. PubMed ID: 10368676
[TBL] [Abstract][Full Text] [Related]
17. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
18. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
[TBL] [Abstract][Full Text] [Related]
19. Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line.
Rusetskaya NV; Khariton N; Yurchenko OV; Chekhun VF
Exp Oncol; 2011 Jun; 33(2):78-82. PubMed ID: 21716203
[TBL] [Abstract][Full Text] [Related]
20. Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells.
Taatjes DJ; Fenick DJ; Koch TH
J Med Chem; 1998 Apr; 41(8):1306-14. PubMed ID: 9548820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
